1. Market Research
  2. > Healthcare Market Trends
France Ultrasound Infertility Diagnosis and Treatment Market by Care Pathway and End User : Opportunity Analysis and Industry Forecast, 2021–2030

France Ultrasound Infertility Diagnosis and Treatment Market by Care Pathway and End User : Opportunity Analysis and Industry Forecast, 2021–2030

  • January 2022
  • 141 pages
  • ID: 6247252
  • Format: PDF
  • Allied Market Research


Table of Contents

France Ultrasound Infertility Diagnosis and Treatment Market by Care Pathway (Infertility Diagnostics, Punction, and Treatment Monitoring) and End User (Public Hospital with Infertility Department, Private Fertility Clinics and Ambulatory Centers): Opportunity Analysis and Industry Forecast, 2021–2030

The France ultrasound infertility diagnosis and treatment market was valued at $336.54 million in 2020, and is estimated to reach $522.36 million by 2030, growing at a CAGR of 4.4% from 2021 to 2030.
Infertility in individuals is defined as the inability of the male or female reproductive system to conceive naturally. Ultrasound-guided infertility diagnosis is a technique in which ultrasound waves are used for determination for the cause of infertility in males as well as females. In females, infertility is caused majorly due to blocked fallopian tubes; sexually transmitted infections (STIs); uterine disorders such as endometriosis, septate uterus, and fibroids; and ovarian disorder such as the polycystic ovarian syndrome (PCOS). On the contrary, in males, obstruction of the reproductive tract, testicular impairment, and hormonal misbalance may result in infertility.
Fertility services help treat infertility in men and women. The different forms of fertility treatments available include in vitro fertilization (IVF), fertility testing, intrauterine insemination, and egg freezing & embryo banking. These treatments are often opted by single mothers, the LGBTQ community, and couples who find it hard to procreate. Ultrasound-guided procedures for infertility diagnosis such as hysterosonography, hysterosonosalpyngography, and hysterosalpingo-foam sonography are used to determine the woman’s uterus for a variety of issues such as vaginal bleeding, recurrent miscarriages, fibroids, polyps, scar tissue, or other abnormalities.

Hysterosonosalpyngography is used to determine the fallopian tubes blockage. Ultrasound-guided trans-vaginal needle aspiration/biopsy and core-needle testicular biopsy in females and males are the minimally invasive techniques that assess infertility diagnosis. Treatment monitoring service such as the ovulation monitoring is one of the majorly used techniques for predicting the ovulation for conceiving through kits and is less expensive.
The major factors that drive the growth of the ultrasound infertility diagnosis & treatment market include increase in prevalence of infertility rates, rise in trend of delayed pregnancies, surge in the number of median age of first-time mothers, increase in awareness of in vitro fertilization (IVF), and technological advancements for infertility diagnosis. According to the World Bank fertility rate, total (births per woman) in France in 2018 was 1.88, and it reduced to 1.87 in 2019. Infertility affects millions of people of reproductive age worldwide and has an impact on their families and communities. Millions of people of reproductive age around the world are affected by infertility, which has an impact on their families and communities. Thus, increase in infertility rates and reduction of birth rates is expected to drive the market growth.
In addition, surge in adoption of sedentary lifestyle; rise in alcohol, smoking, & tobacco consumption; excessive stress; unhealthy lifestyle; and surge in obesity cases are expected to drive the growth of the ultrasound-guided infertility diagnosis & treatment monitoring services market. For instance, in 2019, according to the World Health Organization (WHO) global report on trends in prevalence of tobacco use 2000–2025, the tobacco use rates across the people in France aged 15 years and older, was estimated to be 36.0 in males and 33.2 in males.
Cigarette smoking rates were estimated to be 33.0 in males and 30.0 in females and about 30.9 in 2018. Thus, such high tobacco consumption and smoking is expected to affect the fertility of males and females, which, in turn, drives the growth of the market in France.
Moreover, according to the Organisation for Economic Co-operation and Development (OECD), about 1 in 10 individuals is obese in France, and almost 40% are overweight (including obese). OECD has estimated that overweight rates will increase by a further 10% within 10 years. In addition, according to the Eurostat in 2019, about 40% of French women were overweight, and among this, about 17% of women were obese. ,. Menstrual disorders and anovulation are more common in overweight women. Women who are overweight or obese are at a higher risk of having a miscarriage. These women have a higher risk of subfecundity and infertility as well as conception, miscarriage, and pregnancy problems. Thus, all these factors notably contribute toward the growth of the France ultrasound infertility diagnosis and treatment market.
Furthermore, technological advancements IVF techniques and frozen embryo transfer boost the market growth. For instance, in June 2021, France’s Lower House of Parliament approved a law that will allow single women and lesbians to access medically assisted reproduction for the first time. Thus, provision of access to fertility treatments such as artificial insemination and IVF is expected to strengthen the growth of the market in France.
However, high cost of infertility diagnosis procedures, risk associated after IVF procedure, and high cost of assisted reproductive technology hinder the market growth. On the contrary, initiatives taken by governments for development of the technology sector in infertility and increase in disposable income level of consumers are expected to offer remunerative opportunities for the market growth.
In addition, surge in demand for advanced technologies in healthcare to enhance efficiency of procedures and smooth delivery of babies is expected to open new avenues for the market growth during the forecast period.
The France ultrasound infertility diagnosis and treatment market is segmented into care pathway and end user. On the basis of care pathway, the market is fragmented into infertility diagnostics, punction, and treatment monitoring. The infertility diagnostics segment is further classified into hysterosonography, hysterosonosalpyngography, and hysterosalpingo-foam sonography (HyFoSy). The punction segment is subsegmented into ultrasound-guided trans-vaginal needle aspiration/biopsy and ultrasound guided core-needle testicular biopsy. Moreover, the treatment monitoring segment comprises frozen embryo transfer services and ovulation monitoring.
Depending on end user, the market is segregated into public hospital with infertility department, private fertility clinics and ambulatory centers. Each end user is further segmented into the care pathway bifurcation of infertility diagnostics, punction, and treatment monitoring.

The major players profiled in the report are American Hospital of Paris, Amp Center St Roch, Amp Natecia Lyon, Centre Chirugical (Pierre Cherest Clinic), Fertility Center-Parsi East, Hospital Cochin, Hospital Group Diaconesses Croix Saint-Simon, Maternité Des Bluets - Hospital Pierre Rouquès, Pointgyn-Pleasure and Ramsay Healthcare Limited (Clinique De La Muette).

• This report provides an extensive analysis of the current and emerging market trends and dynamics in the France ultrasound infertility diagnosis and treatment market to identify the prevailing opportunities.
• This study presents the competitive landscape of the market to predict the competitive environment across the country.
• Comprehensive analysis of factors that drive and restrict the market growth is provided.

By Care Pathways
Infertility Diagnostics
Hysterosalpingo-foam Sonography (HyFoSy)
Ultrasound-guided trans-vaginal Needle Aspiration/Biopsy
Ultrasound-guided core-needle Testicular Biopsy
Treatment Monitoring
Frozen Embryo Transfer
Ovulation Monitoring

By End User
Public Hospital with Infertility Department
Infertility Diagnostics
Treatment Monitoring
Private Fertility Clinics
Infertility diagnostics
Treatment Monitoring
Ambulatory Centers
Infertility Diagnostics
Treatment Monitoring

American Hospital of Paris
Amp Center St Roch
Amp Natecia Lyon
Centre Chirugical (Pierre Cherest Clinic)
Fertility Center-Parsi East
Hospital Cochin
Hospital Group Diaconesses Croix Saint-Simon
Maternité Des Bluets - Hospital Pierre Rouquès
Ramsay Healthcare Limited (Clinique De La Muette)

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Sports Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • $ 2499
  • April 2022
  • 108 pages

The global sports medicine market reached a value of US$ 5.8 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 8.1 Billion by 2027, exhibiting a CAGR of 5.7% during 2022-2027. ...

  • World
  • Healthcare
  • Health Insurance
  • Industry analysis
  • Smoking Prevalence

Cough Drugs Markets in China $ 4000 June 2022


Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on